Page URL:

Model predicts chance of having normal embryo as women age

2 July 2018
By Shaoni Bhattacharya
Reporting from the European Society for Human Reproduction and Embryology's 2018 annual meeting in Barcelona
Appeared in BioNews 956

Scientists say they have developed the most robust model yet to estimate how likely a woman is to have a chromosomally normal embryo for IVF depending on her age.

Dr Sanchez Esteves of Aarhus University, Denmark, presented the findings at the European Society of Human Reproduction and Embryology (ESHRE) annual conference in Barcelona, Spain.

'Previous papers actually calculated euploid [embryos with the correct number of chromosomes] probability based on rates, this study is different because we are calculating probability using a mathematical model – it is more robust,' said Dr Esteves.

He and his team looked at about 1120 biopsies from the trophectoderm, also known as the trophoblast, which is the outer layer of cells of a blastocyst. These biopsies came from the embryos of 436 infertile couples undergoing ICSI and preimplantation genetic testing for aneuploidy (PGT-A) between 2016 and 2017.

The team used the data obtained from the biopsies in statistical analyses to come up with seven potential mathematical models. These were then whittled down to the best candidate. 

The likelihood of aneuploidy – having the incorrect number of chromosomes – in an embryo, goes up with a mother's age. The model shows not only that the chance of getting a euploid embryo decreases with a woman's age, but that the odds worsen progressively year on year.

However, Dr Esteves cautioned that other factors might also affect the likelihood of obtaining a normal embryo. 'Here we are considering women's age only.'

The team hope that the research will benefit fertility patients. Dr Esteves noted that the model could be used to work out how many embryos might be needed for assisted reproduction.

'The mathematical formula can estimate the minimum number of blastocysts you need to get at least one euploid blastocyst for transfer,' he said. '[It] could be important to provide transparent information for a patient for us to discuss the treatment options… and to prepare the patient emotionally as well.' 

However, selecting euploid embryos for implantation is not guaranteed to improve IVF success. Some experts think that procedures such as PGT-A mean that viable embryos are discarded (see BioNews 930). 

Such services are among the controversial IVF 'add-ons' and the HFEA currently advises patients that 'there is little evidence showing it improves success rates' particularly in older patients. 

Estimation of age-dependent decrease in blastocyst euploidy in in vitro fertilization/intracytoplasmic sperm injection cycles
ESHRE |  2 July 2018
14 October 2019 - by Dr Laura Riggall 
Inheriting two copies of a chromosome from a single parent is more common than previously thought, according to a new study...
13 August 2018 - by Dr Charlott Repschlager 
Pre-implantation genetic testing of embryos does not improve IVF birth rates in older women, found the largest study of its kind yet...
5 July 2018 - by Shaoni Bhattacharya 
DNA shed from early embryos could one day provide an alternative way of genetically testing them without having to do a biopsy, suggests a small pilot study...
8 January 2018 - by Dr Roy Farquharson 
The European Society of Human Reproduction and Embryology (ESHRE) was created by Robert Edwards and Jean Cohen in 1984. The focus, complexity and growth of ESHRE have shifted dramatically over its 34 years of work, growing to provide leadership in reproductive medicine a global setting. Here is a short history of how the society evolved and a map of where it is heading next...
11 December 2017 - by Norbert Gleicher 
A seemingly brilliant hypothesis of preimplantation genetic screening arose in the 1990s when Dr Yuri Verlinsky proposed using polar body biopsies to detect chromosomal abnormalities in embryos prior to transfer in IVF... Healthy embryos are discarded by unvalidated PGS
5 December 2016 - by Lucas Taylor 
There is a lack of quality evidence on the benefits of almost all fertility clinic add-on treatments, a study published in the BMJ has suggested...
26 September 2016 - by Dr Nicoletta Charolidi 
There was a captivating debate around the emerging genetic choices, legal framework and ethical issues from the use of PGS (pre-implantation genetic screening) and PGD (pre-implantation genetic diagnosis) at this event produced by the Progress Educational Trust (PET)...
18 January 2016 - by Heidi Mertes, Sjoerd Repping & Guido de Wert 
Under the auspices of the Virtual Academy of Genetics, COGEN recently issued a 'consensus statement' on preimplantation genetic screening, based on a scientific meeting held in Paris last September...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.